Rivastigmine (0.5 mg/kg) reduced MPO in the colon by about 40% but this did not quite reach statistical significance.
← all excerpts
Rivastigmine alleviates experimentally induced colitis in mice and rats by acting at central and peripheral sites to modulate immune responses.
1
—
—